Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
- 1 January 1993
- journal article
- case report
- Published by Elsevier in The Lancet
- Vol. 341 (8837) , 85-86
- https://doi.org/10.1016/0140-6736(93)92560-g
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runtBlood, 1992
- An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transferBlood, 1992
- Recovery kinetics after chemotherapy and circulating mononuclear cells expressing the CD34 antigen in pediatric cancer patientsAnnals of Hematology, 1992
- Autologous Bone Marrow Transplant for Children with AML in First Complete Remission: Use of Marker Genes to Investigate the Biology of Marrow Reconstitution and the Mechanism of RelapseHuman Gene Therapy, 1991
- Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purgingBlood, 1990
- Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapyJournal of Virological Methods, 1989
- Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag regionJournal of Virology, 1987
- Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-HydroperoxycyclophosphamideNew England Journal of Medicine, 1986